Efficacy and safety of a novel antiviral preparation in ICU-admitted patients with COVID-19: a phase III randomized controlled trial
Preprint
- 23 November 2021
- preprint
- research article
- Published by Cold Spring Harbor Laboratory
Abstract
Introduction: Despite an increasing number of studies, there is as yet no efficient antiviral treatment developed for the disease. In this clinical trial, we examined the efficacy of a novel herbal antiviral preparation comprising Zataria multiflora Boiss, Glycyrrhiza glabra, Cinnamomum Vermont, Allium sativuml, and Syzygium aromaticum in critically ill patients with COVID-19 patients.Methods: A total number of 120 ICU-admitted patients requiring pulmonary support with a diagnosis of COVID-19 pneumonia were recruited to the trial. Participants were equally randomized to receive either the novel antiviral preparation sublingually, for up to two consecutive weeks or till discharge, or normal saline as the matching placebo. Clinical and laboratory parameters as well as survival rates were compared between the two groups at the study end.Results: The cumulative incidence of death throughout the study period was 8.33% in the medication group and 60% in the placebo group (risk ratio: 0.14; 95% confidence interval [CI], 0.05 to 0.32; P2 were improved in patients treated with the novel antiviral preparation compared with the placebo group.Conclusion: The novel antiviral preparation tested in this trial significantly improved the survival rate and reduced mortality in critically ill patients with COVID-19. Thus, this preparation might be suggested as a potentially promising COVID-19 treatment.Funded by Shimi Teb Salamat Co., Shiraz, Iran, and registered on the Iranian registry of clinical trials (registration No. IRCT20200509047373N2).Keywords
This publication has 27 references indexed in Scilit:
- Disposable face masks and reusable face coverings as non-pharmaceutical interventions (NPIs) to prevent transmission of SARS-CoV-2 variants that cause coronavirus disease (COVID-19): Role of new sustainable NPI design innovations and predictive mathematical modellingScience of The Total Environment, 2021
- Corticosteroid treatment has no effect on hospital mortality in COVID-19 patientsScientific Reports, 2021
- Comparison of the characteristics, morbidity, and mortality of COVID-19 and seasonal influenza: a nationwide, population-based retrospective cohort studyThe Lancet Respiratory Medicine, 2020
- The impact of vaccination on COVID-19 outbreaks in the United StatesmedRxiv, 2020
- COVID-19 in-hospital mortality and mode of death in a dynamic and non-restricted tertiary care model in GermanyPLOS ONE, 2020
- Coronavirus biology and replication: implications for SARS-CoV-2Nature Reviews Microbiology, 2020
- Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)BMJ, 2020
- A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 PandemicFrontiers in Pharmacology, 2020
- Characteristics of Hospitalized Adults With COVID-19 in an Integrated Health Care System in CaliforniaJAMA, 2020
- Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington StateJAMA, 2020